Prevalence of chuA gene virulence factor in Escherichia Coli isolated from clinical samples in AL-Diwaniyah province
Keywords:
E. coli, chuA gene, multidrug resistanceAbstract
The current study aimed to investigate multidrug-resistant E.Coli, and (chuA) gene in Es coli which have virulence factors by PCR. Out of 150 urine and stool samples, 122 gram-negative bacteria (60 isolates belong to E.Coli) and 28 gram-positive bacteria were diagnosed by cultural and biochemical characteristics and API 20E System. The susceptibility test is carrying out for sixteen antibiotics drugs by diffusion method, the results showed that higher resistance to aztreonam was (81.8%), ticarcilin/clavulanic acid was (89.09%), carbencillin was (83.6%), piperacillin was (70.9%), nitrofurantoin was (67.26%). Ceftrixon was (61.8%), the most isolates demonstrated low resistance against levofloxacin (21.8%) and amikacin (43.6%). As it turned out from the study, 40 isolates of Escherichia Coli have multiple resistance to antibiotics (MDR).
Downloads
References
Abdul-Razzaq, M. S., & Abdul-Lateef, L. A. (2011). Molecular phylogeny of Escherichia coli isolated from clinical samples in Hilla, Iraq. African Journal of Biotechnology, 10(70), 15783-15787.
Karam, M. R. A., Habibi, M., & Bouzari, S. (2018). Relationships between virulence factors and antimicrobial Resistance among Escherichia coli isolated from urinary tract infections and commensal isolates in Tehran, Iran. Osong public health and research perspectives, 9(5), 217.
Spurbeck, R. R., Dinh Jr, P. C., Walk, S. T., Stapleton, A. E., Hooton, T. M., Nolan, L. K., ... & Mobley, H. L. (2012). Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infection and immunity, 80(12), 4115-4122.
Salmani, H., Azarnezhad, A., Fayazi, M. R., & Hosseini, A. (2016). Pathotypic and phylogenetic study of diarrheagenic Escherichia coli and uropathogenic E. coli using multiplex polymerase chain reaction. Jundishapur journal of microbiology, 9(2).
Erb, A., Stürmer, T., Marre, R., & Brenner, H. (2007). Prevalence of antibiotic Resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. European Journal of Clinical Microbiology & Infectious Diseases, 26(2), 83-90.
Pitout, J. D. (2012). Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Frontiers in microbiology, 3, 9.
Bergey, D. H. (1994). Bergey's manual of determinative bacteriology. Lippincott Williams & Wilkins.
Clinical and Laboratory Standards Institute (CLSI). (2019). Performance standards for antimicrobial susceptibility testing, CLSI document M100S27.
Clermont O, Bonacorsi S, Bingen E (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66: 4555-4558.
Field, A. (2005) Reliability analysis. In: Field, A., Ed., Discovering Statistics Using spss. 2nd Edition, Sage, London, Chapter 15.
Moreno, E., Andreu, A., Pigrau, C., Kuskowski, M. A., Johnson, J. R., & Prats, G. (2008). Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. Journal of clinical microbiology, 46(8), 2529-2534.
Lee, D. S., Lee, S. J., & Choe, H. S. (2018). Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. BioMed research international, 2018.
Mohammed, M. A.; Alnour, T. M.; Shakurfo, O. M. and Aburass, M. M. (2016). Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya. Asian Pacific Journal of Tropical Medicine, 9(8): 771-776.
Ansari, S.; Nepal, H. P.; Gautam, R.; Shrestha, S.; Neopane, P.; Gurung, G., et al. (2015). Community acquired multidrug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal. Antimicrobial resistance and infection control, 4(1): 15.
Sabir, S., Ahmad Anjum, A.A.; Ijaz, T.; Ali, M.A.; Khan M.U.R. and Nawaz, M. (2014). Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pakistan journal of medical sciences, 30(2), 389–392.
Villagran, Y. Lara, C. Saavedra ,M. Strohmeyer , F. Bartalesi , C. Trigoso and G. M. Rossolini . (2013). Relentless increase of resistance to fluoroquinolones and expandedspectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America. J Clinical Microbiology and Infection; 19: 356-361.
Cohen, S. P., Hächler, H., & Levy, S. (1993). Genetic and functional analysis of the multiple antibiotic Resistance (mar) locus in Escherichia coli. Journal of bacteriology, 175(5), 1484-1492.
Okeke, I. N., Fayinka, S. T., & Lamikanra, A. (2000). Antibiotic Resistance in Escherichia coli from Nigerian students, 1986 1998. Emerging infectious diseases, 6(4), 393.
Oberlé, K., Capdeville, M. J., Berthe, T., Budzinski, H., & Petit, F. (2012). Evidence for a complex relationship between antibiotics and antibiotic-resistant Escherichia coli: from medical center patients to a receiving environment. Environmental science & technology, 46(3), 1859-1868.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Spurbeck, R. R., Dinh Jr, P. C., Walk, S. T., Stapleton, A. E., Hooton, T. M., Nolan, L. K., ... & Mobley, H. L. (2012). Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infection and immunity, 80(12), 4115-4122.
Nègre, V. L., Bonacorsi, S., Schubert, S., Bidet, P., Nassif, X., & Bingen, E. (2004). The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infection and immunity, 72(2), 1216-1220.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
